ABO Incompatible Kidney Transplantation in Indian Children
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Jitendra Meena und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Kidney Transplantation, ABO Blood-Group System, Blood Group Incompatibility, Kidney Failure, Chronic. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Kidney transplantation programs in developing countries chiefly depends on live donors, and waiting lists are long for patients lacking ABO compatible ( ABOc ) donors. ABO incompatible ( ABOi ) transplantation enhances the donor pool. We report our experience of ABOi kidney transplantation in children.
Methods
We screened medical records of ABOi and ABOc kidney transplantation performed at this center between January 2019 to December 2023. For desensitization of ABOi kidney allograft recipients a combination of rituximab and either immunoadsorption or plasma exchange along with IVIg was used. Induction regimen comprised either basiliximab or ATG , followed by maintenance therapy with tacrolimus, mycophenolate mofetil and prednisolone. We retrieved data on recipient and donor characteristics, immunosuppression, and post‐transplant complications. Allograft and patient survival were estimated using Kaplan–Meier survival analysis.
Results
During the 5‐years, 7 ABOi and 46 ABOc kidney transplantation were performed. The mean follow up duration was 24.9 ± 17.1 months in ABOi group and 30.3 ± 18.8 months in ABOc group. Patient age, native kidney disease, donor profile and other characteristics were comparable. Rejection free graft survival was similar between ABOi and ABOc groups ( p = 0.88). Median ( IQR ) eGFR at last follow up was 61.4 (46.6, 74.3) ml/min/1.73 m 2 in ABOi group and 50.9 (39.7, 68.9) ml/min/1.73 m 2 in ABOc group ( p = 0.23). Patients and graft survival rates were similar in both groups.
Conclusions
Our findings suggest that ABOi kidney transplantation in children in India is feasible and associated with satisfactory outcomes P.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
- Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India.
- Department of Transplant Immunology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Jitendra Meena, Aditi Sinha, Virinder Bansal
Förderung
- Indian Council of Medical Research
Zitieren
APA
Meena, J., Sinha, A., Yadav, M., Krishna, A., Bansal, V., Goswami, S., Singh, G., Coshic, P., Hari, P., & Bagga, A. (2025). ABO Incompatible Kidney Transplantation in Indian Children. Pediatric Transplantation. https://doi.org/10.1111/petr.70177
Vancouver
Meena J, Sinha A, Yadav M, Krishna A, Bansal V, Goswami S, et al. ABO Incompatible Kidney Transplantation in Indian Children. Pediatric Transplantation. 2025. doi:10.1111/petr.70177
BibTeX
@article{Meena2025,
author = {Meena, Jitendra and Sinha, Aditi and Yadav, Menka and Krishna, Asuri and Bansal, Virinder and Goswami, Sanjeev and Singh, Geetika and Coshic, Poonam and Hari, Pankaj and Bagga, Arvind},
title = {ABO Incompatible Kidney Transplantation in Indian Children},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70177}
}
EUVIMED